Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Predictions

Ocugen Inc.

Start price
Target price
Perf. (%)
€13.40
03.05.21
€11.00
03.05.22
-19.25%
04.05.21

Stable Large shareholder and/or long term investor
Capable Management
Little innovation
Few uniques
buy
Asit Biotech S.a.

Start price
Target price
Perf. (%)
€0.23
16.04.21
€0.40
16.04.22
103.52%
01.05.21

Could be worthwhile Investment >10% per year
Qualtrics International Inc.

Start price
Target price
Perf. (%)
€37.52
16.02.21
€30.00
-21.35%
24.03.21

Low dividend yield expected
Few uniques
Below average Marketposition
Probably not worthwhile Investment
Ocugen Inc.

Start price
Target price
Perf. (%)
€9.02
17.02.21
€12.00
16.05.21
-1.33%
18.02.21

Could be worthwhile Investment >10% per year
buy
Futu Holdings Ltd.

Start price
Target price
Perf. (%)
€36.20
13.11.20
€109.00
13.05.21
234.25%
12.02.21

Could be worthwhile Investment >10% per year
Revenue growth > 30% per year expected
positive Cash Flow expected
Higher risks for its business
Ocugen Inc.

Start price
Target price
Perf. (%)
€11.35
08.02.21
€8.00
08.02.22
-30.04%
11.02.21

Stable Large shareholder and/or long term investor
Capable Management
Little innovation
Few uniques
buy
Rubius Therapeutics Inc.

Start price
Target price
Perf. (%)
€8.20
14.12.20
€11.00
14.12.21
15.85%
29.01.21

Could be worthwhile Investment >10% per year
Very capable Management
Good culture
Sustainability is little important
Sunworks Inc.

Start price
Target price
Perf. (%)
€24.00
25.01.21
€15.00
25.01.22
-39.58%
28.01.21

Capable Management
Probably not worthwhile Investment
Little innovation
buy
Fastly Inc.

Start price
Target price
Perf. (%)
€74.50
05.12.20
€75.00
8.05%
08.12.20

Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
EBIT growth >5% per year expected
Fair valuation
buy
Alfen

Start price
Target price
Perf. (%)
€66.90
23.11.20
€70.00
13.60%
24.11.20

Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
Fair valuation
ROE higher than 10% per year
buy
Fastly Inc.

Start price
Target price
Perf. (%)
€68.00
19.11.20
€70.00
5.15%
20.11.20

Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
EBIT growth >5% per year expected
Fair valuation
buy
STS Group AG

Start price
Target price
Perf. (%)
€3.07
21.10.20
€3.00
04.11.21
3.26%
10.11.20

Future proof or reliable business model
Could be very worthwhile Investment >20% year
Leading role in innovation
Revenue growth >5% per year expected